Exact Sciences Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Exact Sciences (EXAS) PT Lowered to $38 at Canaccord Genuity After Selling 7M Shares
June 8, 2017 11:33 AM EDTCanaccord Genuity lowered its price target on Exact Sciences (NASDAQ: EXAS) to $38.00 (from $40.00) while maintaining a Buy rating. EXAS announced a raise of 7M shares of common stock at $35/share, to add $245M in gross proceeds and raise its cash balance to ~$500M.... More
